Raymond James & Associates KERYX BIOPHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 11, 2019
SELL
N/A
-11,217 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
N/A
-1,454 Reduced 11.48%
11,217 $38,000
Q2 2018

Aug 14, 2018
BUY
N/A
500 Added 4.11%
12,671 $48,000
Q1 2018

May 14, 2018
SELL
N/A
-3,216 Reduced 20.9%
12,171 $50,000
Q4 2017

Feb 14, 2018
BUY
N/A
1,615 Added 11.73%
15,387 $72,000
Q3 2017

Nov 13, 2017
SELL
N/A
-719 Reduced 4.96%
13,772 $98,000
Q2 2017

Aug 14, 2017
BUY
N/A
14,491
14,491 $105,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email